pharma · Clostridium Difficile Infection · Clostridium Difficile Infection Recurrence · ACXP
Acurx Pharmaceuticals
Acura Pharmaceuticals is a pharma organization headquartered in Palatine, USA. It trades on NYSE under ticker ACXP. Primary therapeutic focus areas include Clostridium Difficile Infection, Clostridium Difficile Infection
Palatine, USA HQ
2003 Founded
9 Employees
Public company Type
ACXP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Palatine, USA
- Founded
- 2003
- Employees
- 9
- Programs
- 2
- Drugs
- 1
- Patents
- 28
Ibezapolstat
Phase 2 · small molecule · Clostridium Difficile Infection
Ibezapolstat for Clostridium Difficile Infection is a Phase 2 program (small_molecule) at Acurx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code ACX-362E-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Acurx Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Clostridium Difficile Infection
- Status
- completed
- Trials
- 1